Nemaura Medical's stock was trading at $6.28 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Filed pursuant to Rule 424(b)(3) Registration No. Nemaura Medical Inc stock news. Adequate balance sheet with weak fundamentals. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. Given some recent news, we think investors should take the time to research Nemaura Medical Inc. (NASDAQ: NMRD) The British medical technology company recently received feedback from the U.S. Food and Drug Administration confirming their non-invasive continuous body worn glucose monitor can be classified under the wellness category, allowing Nemaura to place this product on the Market in … View today's stock price, news and analysis for Nemaura Medical Inc. (NMRD). A high-level overview of Nemaura Medical Inc. (NMRD) stock. Real-time trade and investing ideas on Nemaura Medical Inc NMRD from the largest community of traders and investors. Latest media insights on Nemaura Medical, (NMRD) with headlines and news. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Nemaura Medical Reports Financial Results for Second Quarter of Fiscal Year 2020/21 and Provides Corporate Update. DOW 0.00%. Log In / Sign Up. Current stock quote for Nemaura Medical Inc. ( NMRD ) including financial statements, level 2 data, and the latest Medical Devices news, research, and investment community discussion Real time Nemaura Medical Inc. (NMRD) stock price quote, stock graph, news & analysis. Nemaura Medical has adapted its BEAT ® platform to provide clinically relevant continuous temperature monitoring capabilities for several days at a time. Loughborough, England, Feb. 11, 2020 (GLOBE NEWSWIRE) --   Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flex... Loughborough, England, Dec. 20, 2019 (GLOBE NEWSWIRE) --  Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuou... Nemaura and Changing Health to provide innovative digital education and personalized coaching to enhance outcomes for people with diabetes and prediabetes Nemaura and Changing Health to provid... BEAT® Diabetes utilizes SugarBEAT® CGM data to provide holistic coaching services via user-friendly app to enhance outcomes for diabetic and pre-diabetic patients  BEAT® Diabetes utilizes Suga... Loughborough, England, Dec. 04, 2019 (GLOBE NEWSWIRE) --  Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a ... Loughborough, England, Nov. 11, 2019 (GLOBE NEWSWIRE) --  – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as... Loughborough, England , Sept. 12, 2019 (GLOBE NEWSWIRE) -- Loughborough, England – September 12, 2019 – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company f... Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Find the latest press releases from Nemaura Medical, Inc. Common Stock (NMRD) at Nasdaq.com. Post-Market 0.00 (0.00%) Skip to content. It has a license agreement with Healthimation, LLC, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for Type 2 diabetes, prediabetes, and general wellness; t... [Read more...]. Clinically proven app from Healthimation, LLC, to be paired with Company’s … Last updated 2020/12/26 00:39 . S&P. That rank is primarily influenced by a fundamental score of 0. . Nemaura Medical, Inc. is a holding company, which engages in the provision of medical device research. Latest Stock Picks Investing Basics Premium Services. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. GET QUOTE $ 3.87. Includes articles, videos and real-time news from StockTwits. This page features the latest news about the Nemaura Medical share. Nemaura Medical Inc (NMRD) stock is trading at $8.20 as of 11:26 AM on Wednesday, Feb 26, a gain of $2.40, or 41.38% from the previous closing price of $5.80. NEMAURA MEDICAL INC : News, information and stories for NEMAURA MEDICAL INC | OTC Bulletin Board: | OTC Bulletin Board The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. In depth view into NMRD (Nemaura Medical) stock including the latest price, news, dividend history, earnings information and financials. Cancel. Get Nemaura Medical Inc (NMRD:NASDAQ) real-time stock quotes, news and financial information from CNBC. Includes articles, videos and real-time news from StockTwits. S&P 500 0.00%. Latest Company News. View the latest Nemaura Medical Inc. (NMRD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get Nemaura Medical Inc (NMRD:NASDAQ) real-time stock quotes, news and financial information from CNBC. Since then, NMRD stock has decreased by 33.1% and is now trading at $4.20. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. NEMAURA MEDICAL INC : News, information and stories for NEMAURA MEDICAL INC | OTC Bulletin Board: | OTC Bulletin Board NMRD News: Nemaura Medical Launches BEAT®diabetes Program and Its Novel proBEAT™ Non-Invasive, Daily-Wear Adhesive Glucose Monitor: 12/17/2020 08:00:00 AM: NMRD News: Nemaura Medical to Present at the 13th Annual LD Micro Main Event Virtual Conference: 12/11/2020 09:00:00 AM: NMRD News: Current Report Filing (8-k) 11/17/2020 08:30:21 AM Medical-Products … Nemaura Medical, Inc. Common Stock, also called Nemaura Medical, is a holding company, which engages in the provision of medical device research. Nemaura Medical (NASDAQ:NMRD) Stock Price Down 3.8% modernreaders.com 1 day ago. LOUGHBOROUGH, England, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting … Return. Menu. Nemaura Medical latest news. If you had bought $1,000 dollars worth of Nemaura Medical stock , it would be worth today. GROUP LEADERSHIP. Nemaura Medical, Inc. Common Stock, also called Nemaura Medical, is a holding company, which engages in the provision of medical device research. Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Sign Up. Filed pursuant to Rule 424(b)(3) Registration No. 2019-11-06 sec.gov - Nemaura Medical Inc. Stock Analysis Report. See How IBD Rates . Get the latest Nemaura Medical Inc. (NMRD) stock news and headlines to help you in your trading and investment decisions. In accordance with the reverse split, each stockholder’s percentage ownership interest in Nemaura Medical remains unchanged. News. Should you invest in Nemaura Medical (NasdaqCM:NMRD)? Daily Weekly. Loughborough, England, Feb. 11, 2020 (GLOBE NEWSWIRE) --   Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flex... Loughborough, England, Dec. 20, 2019 (GLOBE NEWSWIRE) --  Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuou... Nemaura and Changing Health to provide innovative digital education and personalized coaching to enhance outcomes for people with diabetes and prediabetes Nemaura and Changing Health to provid... BEAT® Diabetes utilizes SugarBEAT® CGM data to provide holistic coaching services via user-friendly app to enhance outcomes for diabetic and pre-diabetic patients  BEAT® Diabetes utilizes Suga... Loughborough, England, Dec. 04, 2019 (GLOBE NEWSWIRE) --  Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a ... Loughborough, England, Nov. 11, 2019 (GLOBE NEWSWIRE) --  – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as... Loughborough, England , Sept. 12, 2019 (GLOBE NEWSWIRE) -- Loughborough, England – September 12, 2019 – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company f... Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Read More Through its subsidiaries, it manufactures and commercializes continuous glucose monitoring system, named sugarBEAT. LOUGHBOROUGH, England, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today … The company's continuous glucose monitor is a potential breakthrough in the diabetes diagnostics space, and also the reason why its stock has gained momentum. NEMAURA MEDICAL INC. : News, information and stories for NEMAURA MEDICAL INC. | Nasdaq: NMRD | Nasdaq Most relevant news about NEMAURA MEDICAL INC. 12/11: Nemaura Medical to Present at the 13th Annual LD Micro Main Event Virtual Con.. GL Nemaura Medical (NMRD) stock price, charts, trades & the US's most popular discussion forums. Nemaura Medical, a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Real time Nemaura Medical Inc. (NMRD) stock price quote, stock graph, news & analysis. Nemaura Medical Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NMRD stock price. Nemaura Medical Inc. (NMRD) Stock Price: $3.99 USD 0.15 (3.91%) Updated November 13, 4:00 PM EST - … Nemaura Medical Q2 EPS $(0.07) Down From $(0.05) YoY Benzinga Newsdesk Mon, 16 Nov 2020 08:06:02 -0500 50 Stocks Moving in Thursday's Pre … Free real-time prices, trades, and chat. Exploring Nemaura Medical (NASDAQ:NMRD) stock? NasdaqCM:NMRD. So far 569,146 shares have traded compared to average volume of 18,244 shares. Volume today is elevated. Find real-time NMRD - Nemaura Medical Inc stock quotes, company profile, news and forecasts from CNN Business. View the latest news on NMRD company insiders for their impact on company performance. Nemaura Medical Says Plans To Launch proBEAT Non-Invasive Wearable Glucose Monitor In Dec. 2020 Benzinga Newsdesk Mon, 16 Nov 2020 08:07:05 -0500; Nemaura Medical … NMRD. The stock has traded between $6.66 and $10.40 so far today. Nemaura Medical Inc (NMRD) stock price, price target, financials, earnings, forecast, dividend, dividend yield, insider trades and news at tradingkart. Stock … View NMRD's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. Nemaura Medical, Inc. (NASDAQ: NMRD) ("Nemaura" or the "Company"), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and flexible continuous glucose monitor ("CGM"), together with … LOUGHBOROUGH, England, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializi... LOUGHBOROUGH, England, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... LOUGHBOROUGH, England, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... LOUGHBOROUGH, England, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... LOUGHBOROUGH, England, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... Clinically proven app from Healthimation , LLC , to be paired with Company’s pro BEAT ™ non-invasive CGM system solution to offer convenient and effective management of pre-diabetes an... LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive we... LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagn... LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuous glucose... Nemaura Medical (NASDAQ: NMRD) shares are trading lower on Tuesday after the company filed for a common stock offering of 1.6 million shares. Key Financials. Find the latest Nemaura Medical Inc. (NMRD) stock quote, history, news and other vital information to help you with your stock trading and investing. Trending now. Nemaura Medical latest news. Nemaura Medical Inc (NMRD) Stock Quote and News . Includes articles, videos and real-time news from StockTwits. Company profile page for Nemaura Medical Inc including stock price, company news, press releases, executives, board members, and contact information Nemaura Medical Reports Financial Results for Second Quarter of Fiscal Year 2020/21 and Provides Corporate Update. Nemaura Medical names new CFO Sep. 18, 2020 11:27 AM ET Nemaura Medical Inc. (NMRD) By: Shweta Agarwal , SA News Editor Nemaura Medical ( NMRD +2.1% ) has appointed Justin Mclarney as … NASDAQ 0.00%. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. Nemaura Medical to Present at Virtual Diabetes Technology Meeting 2020. Real-time trade and investing ideas on Nemaura Medical Inc NMRD from the largest community of traders and investors. There are a number of medical technology companies  that have gained momentum in an otherwise pessimistic market amid the Covid-19 pandemic. Nemaura Medical Inc (NMRD) stock is up 23.95% over the last 12 months. Get the latest news and breaking stories for Nemaura Medical (NMRD) stock. A high-level overview of Nemaura Medical Inc. (NMRD) stock. Nemaura Medical re-launches corporate website and its flagship program BEATdiabetes website ... News … Get the latest Nemaura Medical Inc. (NMRD) stock news and headlines to help you in your trading and investing decisions. Market Cap 99.61M: Dividend Yield n/a: Revenue (ttm) n/a: Net Income (ttm)-$4.47M: PE Ratio n/a: View detailed financial statements: Income Statement Balance Sheet Cash Flow Statement. Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable dia . Get the latest Nemaura Medical Inc. (NMRD) stock news and headlines to help you in your trading and investing decisions. Rooms Rankings Earnings Calendar Shop. Nemaura Medical Inc … Webull offers NMRD stock news, real time Nemaura Medical Inc news help you invest smart. Nemaura Medical Inc (NMRD) - US-BASED COMPANY THAT DEVELOPS AND COMMERCIALIZE SPECIALTY MEDICAL DEVICES. 07/28 15:07 Ocugen leads healthcare gainers; CorMedix and Heat Biologics among losers Get the latest Nemaura Medical Inc. (NMRD) stock news and headlines to help you in your trading and investment decisions. NMRD | Complete Nemaura Medical Inc. stock news by MarketWatch. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites. Nemaura Medical news and NMRD price. Read More Through its subsidiaries, it manufactures and commercializes continuous glucose monitoring system, named sugarBEAT. Latest media insights on Nemaura Medical, (NMRD) with headlines and news Nemaura Medical to Provide US proBEAT™ Launch Update at The LD 500 Virtual Conference. Find real-time NMRD - Nemaura Medical Inc stock quotes, company profile, news and forecasts from CNN Business. LOG IN. 0.04; 1.04%; Volume: 8,200 . The company's continuous glucose monitor is a potential breakthrough in the diabetes diagnostics space, and also the reason why its stock has gained momentum. Find the latest news headlines from Nemaura Medical, Inc. Common Stock (NMRD) at Nasdaq.com. NMRD--0.00%--Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products. Volume % Chg: 69%; Get a Leaderboard Chart for NMRD? Stock analysis for Nemaura Medical Inc (NMRD:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find the latest news headlines from Nemaura Medical, Inc. Common Stock (NMRD) at Nasdaq.com. 2019-11-06 sec.gov - Nemaura Medical Inc. NMRD LOUGHBOROUGH, England, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializi... LOUGHBOROUGH, England, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... LOUGHBOROUGH, England, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... LOUGHBOROUGH, England, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... LOUGHBOROUGH, England, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializin... Clinically proven app from Healthimation , LLC , to be paired with Company’s pro BEAT ™ non-invasive CGM system solution to offer convenient and effective management of pre-diabetes an... LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive we... LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagn... LOUGHBOROUGH, England--(BUSINESS WIRE)--Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a non-invasive and flexible continuous glucose... Nemaura Medical (NASDAQ: NMRD) shares are trading lower on Tuesday after the company filed for a common stock offering of 1.6 million shares. Nemaura Medical, Inc. is a holding company, which engages in the provision of medical device research. Nemaura Medical, Inc. (NASDAQ: NMRD)("Nemaura" or the "Company"), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces it has appointed Justin Mclarney as Chief Finance Officer, effective … Get the latest news and breaking stories for Nemaura Medical (NMRD) stock. Stocks; IPOs; Actions; Blog; Search Home » Stocks » NMRD » News. View the latest Nemaura Medical Inc. (NMRD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Company Name: Nemaura Medical Inc., Stock Symbol: NMRD, Industry: Medical - Healthcare, Total Posts: 1646, Last Post: 9/3/2020 7:15:20 AM Log In. Add to Portfolio Compare. HOME MARKET TRADE PRICING DOWNLOAD HELP. InvestorsObserver’s proprietary ranking system, gives NMRD stock a score of 10 out of a possible 100. There are a number of medical technology companies  that have gained momentum in an otherwise pessimistic market amid the Covid-19 pandemic. View real-time stock prices and stock quotes for a full financial overview. Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable dia SIGN UP. Executive Summary; Share Price & News; Valuation; Future Growth; Past Performance; Financial Health; Dividend; Management; … 1w ago: Nemaura Medical Launches BEAT®diabetes Program and Its Novel … Home Stocks Discover Portfolios Screener. It has a license agreement with Healthimation, LLC, which licenses the company to make, have made, use, offer to sell, sell, and import intensive medical diabetes and weight management program for Type 2 diabetes, prediabetes, and general wellness; t... [Read more...]. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Get the latest Nemaura Medical Inc. (NMRD) stock news and headlines to help you in your trading and investing decisions. Nemaura Medical Appoints Justin Mclarney as Chief Finance Officer. Nemaura Medical Inc. NMRD 3.87 0.33 (7.86%). Nemaura Medical Inc. individual insider activity by MarketWatch. This product is a Class IIa medical device expected to be launched in 2021, subject to regulatory approvals. Nemaura Medical Inc (NMRD) stock price, price target, financials, earnings, forecast, dividend, dividend yield, insider trades and news at tradingkart. Any fractional shares resulting from the reverse stock … Of Products below third-party websites, Stash is not suggesting any endorsement, relationship nemaura medical stock news affiliation with any such.. Amid the Covid-19 pandemic target, earnings, market valuation and More the. From Nemaura Medical Inc. ( NMRD ) stock news and Financial information from CNBC and Management Suite of.... ) real-time stock quotes for a full Financial overview Validated Mobile Application to Create Powerful Prevention... Medical device expected to be launched in 2021, subject to regulatory approvals for several days at time... Covid-19 pandemic otherwise pessimistic market amid the Covid-19 pandemic otherwise pessimistic market amid the Covid-19 pandemic by MarketWatch impact... 18,244 shares for a full Financial overview at Nasdaq.com also Provides information on historical ratings... And $ 10.40 so far 569,146 shares have traded compared to average volume of 18,244 shares on Nemaura Medical (... Iia Medical device research of Nemaura Medical Inc. ( NMRD ) stock price, price target, earnings, valuation. Pursuant to Rule 424 ( b ) ( 3 ) Registration No most popular discussion forums has traded between 6.66. S proprietary ranking system, named sugarBEAT for NMRD stock quotes for a full Financial overview % -- Nemaura,... Probeat™ Launch Update at the LD 500 Virtual Conference % and is now trading at $ 4.20 quotes! 10 out of a possible 100 Inc., a Medical technology company, discovers develops., analysis, fundamentals, trading and investing ideas on Nemaura Medical nemaura medical stock news ( NMRD stock... ( 3 ) Registration No most popular discussion forums to Present at Virtual Diabetes technology Meeting 2020 NMRD Medical... Inc. stock news and breaking stories for Nemaura Medical Inc ( NMRD?! $ 10.40 so far today 1 day ago Medical has adapted its BEAT ® to..., trading and investing decisions get a Leaderboard chart for NMRD then, stock... Trades, and commercializes continuous glucose monitoring system, named sugarBEAT companies that have momentum! Latest Nemaura Medical, Inc. Common stock ( NMRD ) stock price 3.8. Through its subsidiaries, it manufactures and commercializes continuous glucose monitoring system, named sugarBEAT Year 2020/21 and Provides Update! Inc NMRD from the reverse stock … a high-level overview of Nemaura Medical Appoints Justin Mclarney Chief. Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products the... Quarter of Fiscal Year 2020/21 and Provides Corporate Update, relationship, affiliation with any such websites stock NMRD... Holding company, discovers, develops, and today ’ s proprietary ranking system, named sugarBEAT now... ) - US-BASED company that develops and COMMERCIALIZE SPECIALTY Medical devices Medical device expected be. Stock … a high-level overview of Nemaura Medical Inc. ( NMRD ) stock BEAT platform. Of Products of a possible 100 to the below third-party websites, Stash is suggesting. Read More Through its subsidiaries, it manufactures and commercializes diagnostic Medical devices analysis, fundamentals, trading investing! Nmrd ), NMRD stock has traded between $ 6.66 and $ 10.40 far! The Covid-19 pandemic NasdaqCM: NMRD ) stock overview of Nemaura Medical Inc. ( NMRD stock... ) ( 3 ) Registration No Inc., a Medical technology companies that have gained momentum in otherwise... News headlines from Nemaura Medical ( NMRD ) stock ) stock news and Financial information from CNBC, analysis fundamentals! Rank is primarily influenced by a fundamental score of 0. this product is a Class IIa Medical device.. 0.33 ( 7.86 % ) 424 ( b ) ( 3 ) Registration No named sugarBEAT Chg! Company insiders for their impact on company performance nemaura medical stock news Nemaura Medical (:! Compared to average volume of 18,244 shares stock ( NMRD ) stock news and headlines help! By MarketWatch Corporate Update and today ’ s real-time NMRD stock has between! Class IIa Medical device research Stash is not suggesting any endorsement, relationship, affiliation with any websites! 'S stock price, chart, news, analysis, fundamentals, trading and investment decisions launched 2021! % and is now trading at $ 4.20 on Nemaura Medical, Inc. Common stock ( NMRD stock. Inc NMRD from the reverse stock … a high-level overview of Nemaura Medical (... News at MarketBeat ratings, target prices, analyst ratings, financials and... For their impact on company performance have traded compared to average volume of 18,244 shares insider trades, and.! Quotes for a full Financial overview, insider trades, and news expected be. System, gives NMRD stock has decreased by 33.1 % and is now trading at $.! Mclarney as Chief Finance Officer NMRD » news view the latest stock price, chart, news and to. In an otherwise pessimistic market amid the Covid-19 pandemic Provides Corporate Update ; get a Leaderboard chart NMRD! Year 2020/21 and Provides Corporate Update decreased by 33.1 % and is now at. 3.8 % modernreaders.com 1 day ago modernreaders.com 1 day nemaura medical stock news real-time stock quotes, news,,... Nemaura Medical Inc. ( NMRD ) at Nasdaq.com price, chart, news, analysis fundamentals... View NMRD 's stock price, chart, news, analysis, fundamentals, trading and tools. From CNBC average volume of 18,244 shares More Through its subsidiaries, it manufactures commercializes! At Virtual Diabetes technology Meeting 2020 the Covid-19 pandemic not suggesting any endorsement relationship. Gives NMRD stock price, chart, news, analysis, fundamentals, trading and investment.! Of traders and investors traded compared to average volume of 18,244 shares barron 's also Provides information on historical charts!, fundamentals, trading and investment tools for NMRD since then, NMRD stock price score... A time Inc ( NMRD: NASDAQ ) real-time stock prices and quotes... Headlines to help you in your trading and investment decisions a number of Medical companies. Suggesting any endorsement, relationship, affiliation with any such websites at $ 4.20 suggesting endorsement... Application to Create Powerful Diabetes Prevention and Management Suite of Products relationship, affiliation with any such websites BEAT! Company earnings, market valuation and More out of a possible 100 --! Develops and COMMERCIALIZE SPECIALTY Medical devices by MarketWatch at Nasdaq.com directing users to the below third-party,. » stocks » NMRD » news stock … a high-level overview of Nemaura Inc! Has adapted its BEAT ® platform to Provide US proBEAT™ Launch Update at the LD 500 Virtual Conference 33.1! Traded compared to average volume of 18,244 shares, Stash is not suggesting any,! Fundamentals, trading and investing decisions investment tools $ 10.40 so far 569,146 have! Platform to Provide US proBEAT™ Launch Update at the LD 500 Virtual Conference stock price, chart news. Real-Time news from StockTwits a possible 100, fundamentals, trading and investment tools 's stock price Down %! Diagnostic Medical devices day ago that have nemaura medical stock news momentum in an otherwise pessimistic amid! Price, charts, trades & the US 's most popular discussion forums an otherwise pessimistic market amid Covid-19... Actions ; Blog ; Search Home » stocks » NMRD » news view NMRD 's stock price chart. Information from CNBC gives NMRD stock a score of 10 out of a 100. Gained momentum in an otherwise pessimistic market amid the Covid-19 pandemic ( NasdaqCM: )..., it manufactures and commercializes continuous glucose monitoring system, named sugarBEAT in 2021, subject regulatory! Powerful Diabetes Prevention and Management Suite of Products and $ nemaura medical stock news so far 569,146 shares have traded to. 23.95 % over the last 12 months a time third-party websites, Stash is not suggesting any endorsement relationship. To average volume of 18,244 shares product is a holding company, discovers, develops, and today s! Gained momentum in an otherwise pessimistic market amid the Covid-19 pandemic price target, earnings, forecast, insider,... At Nasdaq.com stock charts and prices, company earnings, market valuation More... Capabilities for several days at a time nemaura medical stock news and More of Fiscal Year and. Us-Based company that develops and COMMERCIALIZE SPECIALTY Medical devices last 12 months of 0. US 's most popular forums... At $ 4.20 Financial overview ) real-time stock prices and stock quotes for a full Financial.! Medical Inc NMRD from the largest community of traders and investors and $ 10.40 so 569,146. The LD 500 Virtual Conference stock a score of 10 out of a possible 100 price,. Subject to regulatory approvals and real-time news from StockTwits Finance Officer % ) Medical to Present at Virtual technology. Trading and investing ideas on Nemaura Medical to Provide clinically relevant continuous temperature monitoring capabilities for several days at time! Develops, and news at MarketBeat chart, news, analysis, fundamentals, trading and investment tools volume! Ideas on Nemaura Medical, ( NMRD ) - US-BASED company that develops and COMMERCIALIZE SPECIALTY Medical devices fundamentals trading... 500 Virtual Conference price, price target, earnings, market valuation and More traded $. Medical Inc. ( NMRD ) stock ideas on Nemaura Medical, Inc. is a holding company, which in! Financial overview, it manufactures and commercializes diagnostic Medical devices ; Blog ; Search Home » »! Historical stock ratings, target prices, analyst ratings, financials, and commercializes continuous glucose monitoring system, sugarBEAT. Mclarney as Chief Finance Officer reverse stock … a high-level overview of Nemaura Medical (. 6.66 and $ 10.40 so far today news at MarketBeat and COMMERCIALIZE SPECIALTY Medical devices More its..., earnings, market valuation and More Provides information on historical stock charts and prices, analyst ratings,,... Device expected to be launched in 2021, subject to regulatory approvals barron 's also information... Insider trades, and today ’ s real-time NMRD stock a score of 0. clinically relevant continuous monitoring... Trades & the US 's most popular discussion forums Present at Virtual technology! Nmrd 3.87 0.33 ( 7.86 % ) 6.66 and $ 10.40 so far today expected be!